Table 3.
Genes Down-Regulated in Advanced Stage 2A Compared to Earlier Stage PB1 Lymphoma Cells
Genes | Fold decrease |
---|---|
Group A (putative inhibitiors of cell signaling) | |
Protein tyrosine phosphatase 1C* | 8 |
Protein tyrosine phosphatase gamma* | 5 |
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2 | 11 |
Protein tyrosine phosphatase (tissue type: foreskin) | 17 |
cAMP-dependent 3′,5′-cyclic phosphodiesterase 4* | 5 |
CD45* | 10 |
Group B (mediators of cell adhesion) | |
Fibronectin receptor beta subunit* | 5 |
Laminin gamma-1 chain* | 9 |
Leukocyte adhesion glycoprotein LFA-1 alpha chain* | 13 |
Vascular cell adhesion protein-1 | 14 |
Platelet endothelial cell adhesion molecule | 11 |
Cadherin 5 | 6 |
Thrombin receptor* | 15 |
Testican | 26 |
Group C (genes involved in DNA repair and cell apoptosis) | |
Ataxia-telangiectaxia group-D-associated protein* | 23 |
D4-GTPase dissociation inhibitor protein* | 63 |
Annexin I | 7 |
TNF-related apoptosis inducing ligand TRAIL* | 9 |
Granzyme H* | 11 |
Guanine nucleotide regulatory protein (nep1)* | 9 |
Cathepsin L* | 6 |
Glutaredoxin* | 10 |
Group D (negative regulator of cell cycle progression) | |
P16 (cyclin-dependent kinases regulatory subunit 1) | 5 |
Group E (miscellaneous) | |
T-cell receptor alpha chain* | 20 |
Natural Killer cell G7 protein* | 12 |
Human (2′-5′) oligo A synthetase E | 7 |
Thromboxane A synthase* | 6 |
Complement factor H* | 6 |
Tonsillar lymphocyte LD78 beta protein* | 8 |
Macrophage capping protein | 8 |
Low-density lipoprotein receptor | 9 |
Mac-2 binding protein* | 9 |
Ankyrin G | 9 |
Drebrin E | 10 |
FLI-1 oncogene* | 10 |
Beta-2 adrenergic receptor* | 13 |
Interferon-induced guanylate-binding protein-1 | 17 |
Antileukoproteinase-1* | 16 |
Glia-derived nexin* | 20 |
Guanine nucleotide-binding protein alpha- 16 subunit* | 19 |
Placental calcium-binding protein | 24 |
*Identify of the clones as defined by the provider was additionally confirmed by us by resequencing.